Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2 - and TET2 -Mutant Acute Myeloid Leukemia
Shih, Alan H., Meydan, Cem, Shank, Kaitlyn, Garrett-Bakelman, Francine E., Ward, Patrick S., Intlekofer, Andrew M., Nazir, Abbas, Stein, Eytan M., Knapp, Kristina, Glass, Jacob, Travins, Jeremy, StralLanguage:
english
Journal:
Cancer Discovery
DOI:
10.1158/2159-8290.CD-16-1049
Date:
February, 2017
File:
PDF, 5.17 MB
english, 2017